|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
在中国受试者中评价JTM201注射液用于改善中度至重度眉间纹的安全性及有效性的Ⅰ期临床研究
[Translation] A phase I clinical study evaluating the safety and efficacy of JTM201 injection in improving moderate to severe glabellar lines in Chinese subjects
主要目的:初步评价在中国中度至重度眉间纹受试者中单次给予20U JTM201注射液的耐受性和安全性;
次要目的:评价JTM201注射液用于改善中度至重度眉间纹的有效性。
[Translation] Main purpose: To preliminarily evaluate the tolerability and safety of a single administration of 20U JTM201 injection in Chinese subjects with moderate to severe glabellar lines;
Secondary purpose: To evaluate the effectiveness of JTM201 injection in improving moderate to severe glabellar lines.
Multicenter, Randomized, Double-blind, Placebo-controlled, Single-dose Phase 2 Study of the Safety and Efficacy of JTM201 (Botulinum Toxin Type A) to Treat Moderate or Severe Glabellar Lines
This is Multicenter, Randomized, Double-blind, Placebo-controlled, Single-dose Study to evaluate Safety and Efficacy of JTM201 in patients with Moderate or Severe Glabellar Lines
100 Clinical Results associated with Jetema Co., Ltd.
0 Patents (Medical) associated with Jetema Co., Ltd.
100 Deals associated with Jetema Co., Ltd.
100 Translational Medicine associated with Jetema Co., Ltd.